ROCA® for the diagnosis of ovarian cancer
NIHR HSRIC
Record ID 32016000474
English
Authors' objectives:
The Risk of Ovarian Cancer Algorithm, ROCA®, offered by Abcodia Ltd., is a new way of testing women for ovarian cancer. It is intended for use in postmenopausal women between 50 and 85; or women who are considered at higher risk of ovarian cancer by virtue of their family history of ovarian or breast cancer and/or a known genetic cause, such as inheritance of BRCA1 or BRCA2 mutations.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.hsric.nihr.ac.uk/topics/roca-for-the-diagnosis-of-ovarian-cancer/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Humans
- CA-125 Antigen
- Female
- Ovarian Neoplasms
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.